Trademark: 90458567
Word
AMONDYS 45 (CASIMERSEN)
Status Date
Tuesday, November 16, 2021
Registration Number
6564415
Registration Date
Tuesday, November 16, 2021
Filing Date
Monday, January 11, 2021
Published for Opposition
Tuesday, July 27, 2021
5 Pharmaceutical preparations featuring antisense oligonucleotides, for the treatment of neuromuscular diseases and disorders
"45 (CASIMERSEN)"
The mark consists of a hexagon, bisected by a swoosh, followed by the text and numeral "AMONDYS 45" over the text "(casimersen)".
AMONDYS FORTY FIVE (CASIMERSEN); AMONDYS FOUR FIVE (CASIMERSEN)
Nov 16, 2021
Registered-Principal Register
Oct 13, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 12, 2021
Allowed Principal Register - Sou Accepted
Oct 12, 2021
Statement Of Use Processing Complete
Sep 27, 2021
Use Amendment Filed
Oct 12, 2021
Case Assigned To Intent To Use Paralegal
Sep 27, 2021
Teas Statement Of Use Received
Sep 21, 2021
Noa E-Mailed - Sou Required From Applicant
Jul 27, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 27, 2021
Published For Opposition
Jul 7, 2021
Notification Of Notice Of Publication E-Mailed
Jun 24, 2021
Approved For Pub - Principal Register
Jun 24, 2021
Examiner's Amendment Entered
Jun 24, 2021
Notification Of Examiners Amendment E-Mailed
Jun 24, 2021
Examiners Amendment E-Mailed
Jun 24, 2021
Examiners Amendment -Written
Jun 23, 2021
Teas/Email Correspondence Entered
Jun 22, 2021
Correspondence Received In Law Office
Jun 22, 2021
Teas Response To Office Action Received
Jun 2, 2021
Notification Of Non-Final Action E-Mailed
Jun 2, 2021
Non-Final Action E-Mailed
Jun 2, 2021
Non-Final Action Written
May 29, 2021
Assigned To Examiner
Apr 13, 2021
Notice Of Design Search Code E-Mailed
Apr 10, 2021
New Application Office Supplied Data Entered In Tram
Jan 14, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
